A cross-sectional internet-based patient survey of the management strategies for gout

Table 2 Multivariate-adjusted odds of ULT prescription, the choice of ULT as the gout treatment (ULT vs. others), adherence to ULT >80 % and likelihood of lifelong diet change as treatment for gout by gender, race and age

Patient characteristics	ULT prescribed^a	Choice of ULT as the treatment for gout^b	Urate-lowering medication adherence >80 %^c	Likelihood of diet change with score of >8 (range, 0–10)^d
Gender	P = 0.58	P = 0.03	P = 0.32	P = 0.41
Male	1.13 (0.74, 1.71)	0.61 (0.39, 0.95)^a	0.68 (0.31, 1.47)	0.84 (0.55, 1.28)
Female	Ref	Ref	Ref	Ref
Age groups	P = 0.87	P = 0.16	P = 0.71	P = 0.023
21–40 years	1.39 (0.40, 4.71)	0.76 (0.22, 2.67)	0.81 (0.07, 9.05)	2.59 (0.51, 13.06)
41–60 years	1.14 (0.37, 3.53)	1.02 (0.32, 3.27)	1.01 (0.11, 9.26)	2.91 (0.63,13.58)
61–80 years	1.10 (0.34, 3.35)	0.64 (0.20, 2.08)	1.43 (0.16, 13.12)	4.76 (1.01, 22.37)*
>80 years	Ref	Ref	Ref	Ref
Race	P = 0.99	P = 0.60	P = 0.77	P = 0.48
African American	1.10 (0.41, 2.80)	0.91 (0.45, 1.85)	0.49 (0.11, 2.24)	1.35 (0.68, 2.70)
Hispanic or Latino	1.04 (0.33, 3.24)	0.92 (0.31, 2.77)	0.86 (0.09, 7.94)	1.13 (0.36, 3.54)
Asian	0.78 (0.19, 3.25)	0.59 (0.31, 1.12)	2.04 (0.76, 5.47)	0.63 (0.31, 1.29)
American Indian or Alaskan native	0.95 (0.31,2.89)	---	---	3.60 (0.31, 41.22)
Hawaiian or Pacific Islander	-----	4.15 (0.49, 35.11)	1.19 (0.13, 11.28)	2.23 (0.58, 8.52)
Other	0.96 (0.19, 4.83)	0.90 (0.34, 2.35)	1.60 (0.29, 8.76)	1.46 (0.56, 3.82)
White/Caucasian	Ref	Ref	Ref	Ref

*p-value <0.05
---, no odds ratio calculable since no patients in this category
^aReference category is ULT was not prescribed
^bReference category is preference for non-pharmacological treatment options (cherry extract or gout-specific diet modification) for gout
^cReference category is urate-lowering medication adherence of ≤80 % in the last month
^dReference category is the likelihood of diet change with a score ≤8 (range 0–10)

ISSN: 2662-7671